Correlation Between GelStat Corp and Aquestive Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GelStat Corp and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GelStat Corp and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GelStat Corp and Aquestive Therapeutics, you can compare the effects of market volatilities on GelStat Corp and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GelStat Corp with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GelStat Corp and Aquestive Therapeutics.

Diversification Opportunities for GelStat Corp and Aquestive Therapeutics

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between GelStat and Aquestive is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding GelStat Corp and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and GelStat Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GelStat Corp are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of GelStat Corp i.e., GelStat Corp and Aquestive Therapeutics go up and down completely randomly.

Pair Corralation between GelStat Corp and Aquestive Therapeutics

Given the investment horizon of 90 days GelStat Corp is expected to generate 3.47 times more return on investment than Aquestive Therapeutics. However, GelStat Corp is 3.47 times more volatile than Aquestive Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.1 per unit of risk. If you would invest  0.09  in GelStat Corp on September 1, 2024 and sell it today you would lose (0.05) from holding GelStat Corp or give up 55.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

GelStat Corp  vs.  Aquestive Therapeutics

 Performance 
       Timeline  
GelStat Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in GelStat Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, GelStat Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.
Aquestive Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Aquestive Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

GelStat Corp and Aquestive Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GelStat Corp and Aquestive Therapeutics

The main advantage of trading using opposite GelStat Corp and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GelStat Corp position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.
The idea behind GelStat Corp and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets